TABLE 1.
Participant characteristics at baseline.
| RT-HIIT, n = 30 | AT-HIIT, n = 27 | UC, n = 29 | |
|---|---|---|---|
| Age (yr) | 52.2 ± 10.1 | 53.9 ± 7.4 | 52.9 ± 10.1 |
| BMI (kg·m−2) | 24.2 ± 3.6 | 24.2 ± 3.4 | 24.7 ± 4.4 |
| Menopausal status | |||
| Premenopausal | 16 (53.3) | 10 (37.0) | 10 (34.5) |
| Postmenopausal | 14 (46.7) | 17 (63.0) | 19 (65.5) |
| Comorbidities | 6 (20.0) | 4 (14.8) | 10 (34.5) |
| Current smoker | 1 (3.3) | 0 (0.0) | 1 (3.4) |
| Tumor profile | |||
| Triple negative | 1 (3.3) | 5 (18.5) | 6 (20.7) |
| HER2+, ER+, PR+ | 6 (20.0) | 5 (18.5) | 1 (3.4) |
| HER2+, ER−, PR− | 0 (0.0) | 2 (7.4) | 4 (13.8) |
| HER2−, ER+, PR+ | 17 (56.7) | 10 (37.0) | 14 (48.3) |
| HER2−, ER+, PR− | 3 (10.0) | 4 (14.8) | 2 (6.9) |
| HER2+, ER+, PR− | 3 (10.0) | 1 (3.7) | 1 (3.4) |
| HER2−, ER−, PR+ | 0 (0.0) | 0 (0.0) | 1 (3.4) |
| Chemotherapy regimen | |||
| Anthracycline | 12 (40.0) | 10 (37.0) | 11 (37.9) |
| Taxane | 2 (6.7) | 2 (7.4) | 0 (0.0) |
| Anthracycline + taxane | 10 (33.3) | 9 (33.3) | 11 (37.9) |
| Anthracycline + taxane + herceptin | 6 (20.0) | 6 (22.2) | 7 (24.1) |
| MVPA (min·d−1) | 92.6 ± 32.8 | 83.3 ± 28.6 | 68.0 ± 30.4 |
| SED (min·d−1) | 535.5 ± 104.4 | 555.0 ± 74.8 | 555.4 ± 93.1 |
Continuous variables are presented as mean ± SD, whereas dichotomous or categorical variables are presented as n (%).
MVPA, objectively measured moderate to vigorous physical activity; SED, objectively measured sedentary behavior.